July 2010
Note
Chem. Pharm. Bull. 58(7) 957—960 (2010)
957
Production of Polyselenodipenicillamines, Unique Selenium Compounds
Hiroyuki NISHIDA, Motozumi ANDO, Kazuo ITOH, Koji UEDA, Yujiro NISHIDA, Yoshinori OKAMOTO,
Chitose TODA, and Nakao KOJIMA*
Faculty of Pharmacy, Meijo University; 150 Yagotoyama, Tempaku-ku, Nagoya 468–8503, Japan.
Received January 6, 2010; accepted April 12, 2010; published online April 15, 2010
Selenite (H2SeO3) reacts with thiol compounds (RSH) under acidic conditions to form selenotrisulfides
(RSSeSR, i.e. monoselenodithiols). The stoichiometry of the reaction is proposed as 4RSH؉H2SeO3→RSSeSR؉
RSSR؉3H2O. Surprisingly, we found novel polynuclear selenium-containing compounds, i.e. polyselenodipenicil-
lamines (PenSSe2–4SPen), in the reaction of D-penicillamine (PenSH) with H2SeO3. The selenium-centered fea-
1
tures of PenSSe2–4SPen were determined by H-NMR and LC-MS/MS analyses, showing that the selenium iso-
tope abundance patterns of the compounds were in good agreement with the theoretically-calculated ones. In
order to better understand the mechanisms for PenSSe2–4SPen production, various molar ratio of H2SeO3 (1/8 to
4 times of PenSH) was reacted with PenSH, and the concentration of the products was calculated from integral
values of dimethyl proton signals for PenSSe1–2SPen as compared with methyl proton signals for acetic acid (an
internal standard). Total PenSSe1–2SPen concentration was increased with increasing of H2SeO3, in which con-
comitant decrease of PenSSPen (disulfide form of PenSH) was observed. Based on these results, we proposed the
PenSSe2-4SPen production mechanisms being involved in penicillamine selenopersulfides (PenSSe1–2H).
Key words selenium; polyselenodithiol; selenotrisulfide; penicillamine; cancer chemoprevention
Selenium is an essential micronutrient that is known to selenium metabolism, leading to selenium-mediated cancer
play an important role in many physiological functions of the prevention.5) The formation of selenodiglutathione, seleno-
human body. Recent studies have shown that selenium sup- cysteineglutathione, and selenodicysteine was demonstrated
plements in the diet can reduce the risk of cancer and other based on the models of selenium metabolism in cell-free sys-
diseases.1,2) To produce unique selenium compounds leading tems and in rats by Gabel-Jensen et al.6) and by Braga et al.,7)
to the therapeutic application, the reaction chemistry of sele- who proposed the formation of selenide species—selenoper-
nium should be studied in greater detail. Selenite (H2SeO3) sulfide (RSSeH), hydrogen selenide (H2Se), and hydrogen se-
reacts with thiol compounds (RSH) under acidic conditions lenide anion (HSeϪ)—through the reduction of RSSeSR. Re-
to form selenotrisulfides (RSSeSR), which was first de- cently, selenodipenicillamine (PenSSeSPen), a chemically
scribed by Painter using cysteine.3) Reactions of glutathione, stable RSSeSR, was isolated and its bioavailability in mice
cysteine, and 2-mercaptoethanol with H2SeO3 in a molar was investigated by Nakayama et al.8,9) In our study aiming
ratio of 4 : 1 under acidic conditions lead to form selen- at discovering novel selenium compounds, the reaction of D-
odiglutathione, selenodicysteine, and selenodi-2-mercap- penicillamine (PenSH) with H2SeO3 was found to yield poly-
toethanol, respectively.4) Painter and Ganther proposed the selenodipenicillamines (PenSSe2–4SPen), which had been
following reaction, 4RSHϩH2SeO3→RSSeSRϩRSSRϩ overlooked previously (Chart 1). We describe herein the syn-
3H2O.
In biological systems, RSSeSR derived from glutathione
and cysteine have been reported to play an important role in
thesis and characterization of PenSSe2–4SPen.
Experimental
Preparation of PenSSe2–4SPen PenSSe2–4SPen were prepared by mix-
ing with 10 mM PenSH (Tokyo Kasei Kogyo, Tokyo, Japan) and 40 mM
H2SeO3 (Wako Pure Chemical, Osaka, Japan) in 400 ml of 2.5 mM HCl.
1
PenSSe2–4SPen production was confirmed using LC-MS/MS and H-NMR.
Products were purified using preparative HPLC equipped with reversed-
phase column (Develosil C-18, 250ϫ20 mm i.d., 5 mm-pore size, Nomura
Chemical, Aichi, Japan) and were analyzed by LC-MS/MS and 1H-NMR.
LC-MS/MS Analysis of PenSSe2–4SPen LC-MS/MS experiments were
conducted using an Agilent 1100 Series HPLC system (Agilent Technolo-
gies Japan Ltd., Tokyo, Japan) coupled to an LCQ DECA XP ion trap mass
spectrometer (Thermo Fisher Scientific, Kanagawa, Japan). LC was carried
out using a reversed-phase column (Develosil C-18, 50ϫ4.6 mm i.d., 3 mm-
pore size, Nomura Chemical). Mobile phase A consisted of 0.05% formic
acid and mobile phase B consisted of methanol. The separation of
PenSSe0–4SPen was performed in 15 min using a linear gradient elution from
A to B at a flow rate of 0.8 ml/min.
1H-NMR Analysis 1H-NMR spectra were obtained using an ECP500
spectrometer (Jeol Ltd., Tokyo, Japan). All NMR spectra were measured in
D2O (Wako) unless otherwise indicated and the signal positions are ex-
pressed in parts per million (ppm) based on the D2O signal as a reference at
4.80 ppm.
Results and Discussion
As shown in Fig. 1, through LC-MS analysis, we found
Chart 1
∗ To whom correspondence should be addressed. e-mail: kojiman@meijo-u.ac.jp
© 2010 Pharmaceutical Society of Japan